Clotrimazole updated on 01-29-2025

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
All congenital malformations (majors, minors, majors and minors, or unspecified)1.04 [0.93, 1.17]0%3 studies30,9903,830not evaluable ROB-
Cleft lip with or without cleft palate0.86 [0.48, 1.54]0%3 studies2,2882,516not evaluable ROB-
Congenital heart defects0.94 [0.73, 1.20]0%3 studies8,9652,542not evaluable ROB-
Gastroschisis1.31 [0.21, 8.40]0%2 studies658508not evaluable ROB-
Hypospadias1.04 [0.66, 1.64]0%2 studies3,171541not evaluable ROB-
Major congenital malformations1.03 [0.88, 1.20]29%2 studies24,4262,744not evaluable ROB-
Neural Tube Defects0.92 [0.48, 1.78]0%2 studies1,952254not evaluable ROB-
Ano-rectal atresia and stenosis3.27 [0.40, 26.73]-1 study2098not evaluable ROB-
Bilateral renal agenesis including Potter syndrome0.61 [0.04, 9.82]-1 study54498not evaluable ROB-
Cleft palate0.52 [0.09, 2.93]-1 study506500not evaluable ROB-
Club foot / Talipes equinovarus1.14 [0.68, 1.92]-1 study2,009530not evaluable ROB-
Craniosynostosis3.06 [0.63, 14.78]-1 study4479not evaluable ROB-
Diaphragmatic hernia1.16 [0.07, 20.32]-1 study2757not evaluable ROB-
Digestive system anomalies1.30 [0.64, 2.63]-1 study3071,993not evaluable ROB-
Ear malformations1.12 [0.16, 7.98]-1 study282500not evaluable ROB-
Genital anomalies0.98 [0.12, 7.98]-1 study84500not evaluable ROB-
Hydrocephaly1.67 [0.27, 10.30]-1 study284503not evaluable ROB-
Limb defects1.04 [0.73, 1.49]-1 study1,4581,993not evaluable ROB-
Limb reduction defects (LRD)1.03 [0.36, 2.97]-1 study448507not evaluable ROB-
Microcephaly / Small head circumference for gestational age0.30 [0.11, 0.85]-1 study10945not evaluable ROB6.12 [.; 1.64]
Nervous system anomalies1.11 [0.69, 1.78]-1 study8071,993not evaluable ROB-
Oesophageal atresia with or without tracheo-oesophageal fistula5.60 [0.55, 56.88]-1 study2214not evaluable ROB-
Polydactyly1.29 [0.63, 2.64]-1 study1,372518not evaluable ROB-

Long term consequences
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Leukemia0.94 [0.39, 2.25]-1 study24324not evaluable ROB-

Intrauterine deaths
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Early intrauterine death (< 22 weeks)1.05 [0.89, 1.24]-1 study6,4612,712not evaluable ROB-

Hide endpoints reported in only one study ...